Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 87 for “"Alendronate"”.

  1. Alendronate reduces periosteal microperfusion in vivo

    zurich Restricted access

  2. Controlled release of alendronate from polymeric films

    … for the determination of the bisphosphonate, alendronate, was developed and validated. Novel alendronateloaded biodegradable polymeric films were prepared, which could be used as a targeted drug delivery device in areas where predictable bone ingrowth was desired. The drug release profiles of …

    ubc Repository record for Controlled release of alendronate from polymeric films (opens in a new tab) Download PDF for Controlled release of alendronate from polymeric films (opens in a new tab)

  3. Measuring the Nanoindentation Properties of Alendronate-Time Treated Canine Cortical

    … (energy inclusive) properties of 0.2 mg/kg alendronate treated ribs at one and three years against a vehicle treated control in a fresh-frozen, non-cold-mounted, condition. This was to verify if the tissue-level properties for 0.2 ALN treated beagles would increase because of an increased …

    calpoly Repository record for Measuring the Nanoindentation Properties of Alendronate-Time Treated Canine Cortical (opens in a new tab)

  4. Computational Model of Alendronate Effects on Canine Rib Remodeling and Microdamage

    … can be reduced by increasing bone mass. Alendronate is type of bisphosphonate that is approved by the Food and Drug Administration (FDA) to treat postmenopausal osteoporosis by suppressing basic multicellular unit (BMU) remodeling and increasing bone mass. The long term effects of …

    calpoly Repository record for Computational Model of Alendronate Effects on Canine Rib Remodeling and Microdamage (opens in a new tab)

  5. Alendronate treatment elicits a reduction in fatigue-life of canine cortical bone

    … bone tissue after bisphosphonate treatment with alendronate (Aln). 1 1th ribs from 36 skeletally mature female beagles (1-2 years of age) treated daily with either a vehicle control (Cont, 1mL/kg saline) or Aln (0.2 or 1.0 mg/kg) for 3 years were evaluated. From both medial and lateral cortices, …

    njit Repository record for Alendronate treatment elicits a reduction in fatigue-life of canine cortical bone (opens in a new tab)

  6. The Effect of Alendronate and Risedronate on Bone Remodeling in the Canine Maxilla

    … to histomorphometrically quantify the effects of alendronate and risedronate therapy on alveolar bone of the dog maxilla (MX) and to determine if this site is affected differently than the cortical bone in the rib (R) from these same animals. Twenty-two female dogs were divided into three …

    iupui Repository record for The Effect of Alendronate and Risedronate on Bone Remodeling in the Canine Maxilla (opens in a new tab)

  7. Alendronate Alters Single Cell Gene Expression of Cortical Osteoblast Lineage Cells During Bone Loss

    … without the anti-resorptive bisphosphonate drug Alendronate, an effective FDA approved therapeutic for slowing bone loss in association with osteoporosis. To administer Alendronate, mice were treated with 100 μg/kg Alendronate weekly via intraperitoneal (IP) injections. After a 16- week period …

    dominican Repository record for Alendronate Alters Single Cell Gene Expression of Cortical Osteoblast Lineage Cells During Bone Loss (opens in a new tab)

  8. Cost effectiveness of alendronate to reduce hip fractures from osteoporosis in Icelandic postmenopausal women

    … effective to treat postmenopausal women with alendronate to prevent hip fractures. The focus is on Icelandic women. Design: A Markov model was developed to model the disease progression for women 65 years of age to 85 years of age which is the average life expectancy for women in Iceland. Cost …

    bu Repository record for Cost effectiveness of alendronate to reduce hip fractures from osteoporosis in Icelandic postmenopausal women (opens in a new tab) Embargoed until 2999-01-01

  9. Will Topical Application of Alendronate Disodium to Dental Roots Reduce Osteoclast Adherence and Resorption in Vitro?

    … treatment and the second group was soaked in 2mM Alendronate Disodium prior to transfer to culture. All sections were then plated in sterile culture wells with osteoclast precursor cells derived from whole human blood. The sections remained in culture until completion of osteoclastic …

    umn Repository record for Will Topical Application of Alendronate Disodium to Dental Roots Reduce Osteoclast Adherence and Resorption in Vitro? (opens in a new tab)

  10. The Effect of Alendronate and Risedronate on Bone Microdamage Accumulation Surrounding the First Mandibular Molar in Dogs

    … the microdamage effect of the bisphosphonates alendronate and risedronate therapy on alveolar bone surrounding the first mandibular molar in the dog to determine if this response differs from that in non-bisphosphonate treated dogs. Thirty-four dogs were randomly assigned in two test, and one …

    iupui Repository record for The Effect of Alendronate and Risedronate on Bone Microdamage Accumulation Surrounding the First Mandibular Molar in Dogs (opens in a new tab)

  11. Effects of alendronate-immobilized calcium phosphate coating on bone growth into porous tantalum : a gap model animal study

    … is insufficient to allow adequate bone ingrowth. Alendronate, one of the bisphosphonate families, affects the activities of bone cells and enhances bone formation. In this thesis, we hypothesized that the addition of alendronate could increase the osteoconductivity and bone-ingrowth of porous …

    ubc Repository record for Effects of alendronate-immobilized calcium phosphate coating on bone growth into porous tantalum : a gap model animal study (opens in a new tab) Download PDF for Effects of alendronate-immobilized calcium phosphate coating on bone growth into porous tantalum : a gap model animal study (opens in a new tab)

  12. ZOLENDRONATE E ALENDRONATE DOSING IN BONE SEQUESTRA FROM BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAWS: A MULTICENTER OBSERVATIONAL STUDY

    Bisphosphonates (BP), syntetic analogues of inorganic pyrophosphate are able to inhibit the osteoclastic activity, quickly bonding the mineral component of bone structure. BPs are excreted unchanged by glomerul filtration in urine, except for a very small fraction, which is excreted in the bile. …

    milano Repository record for ZOLENDRONATE E ALENDRONATE DOSING IN BONE SEQUESTRA FROM BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAWS: A MULTICENTER OBSERVATIONAL STUDY (opens in a new tab)

Page 1 of 5